University of Nebraska Medical CenterOmaha, Nebraska, United States
Disclosure information not submitted.
SAT-603 - Targeted Liver Fibrosis Assessment in Patient with Metabolic Dysfunction
Saturday, June 13, 20269:30 AM - 4:30 PM CT
SUN-648 - Evaluating Factors Associated with A Favorable Response to A Combination of SGLT2 Inhibitors and GLP-1 Receptor Agonists Versus Either Agent Alone in Patients with Type 2 Diabetes Mellitus (T2DM) in Veterans Affairs Health Care System
Sunday, June 14, 20269:00 AM - 4:00 PM CT
.jpg)
.jpg)